Literature DB >> 21835136

Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit.

Eric Levesque1, Emir Hoti, Daniel Azoulay, Philippe Ichaï, Houssam Habouchi, Denis Castaing, Didier Samuel, Faouzi Saliba.   

Abstract

BACKGROUND & AIMS: Cirrhotic patients admitted to an Intensive Care Unit (ICU) have a poor prognosis. Identifying patients in whom ICU care will be useful can be challenging. The aim of this study was to assess the predictive value of prognostic scores with respect to mortality and to identify mortality risk factors.
METHODS: Three hundred and seventy-seven cirrhotic patients admitted to a Liver ICU between May 2005 and March 2009 were enrolled in this study. Their average age was 55.5±11.4 years. The etiology of cirrhosis was alcohol (68%), virus hepatitis (18%), or mixed (5.5%). The main causes of hospitalization were gastrointestinal hemorrhage (43%), sepsis (19%), and hepatic encephalopathy (12%).
RESULTS: ICU and in-hospital mortality rates were 34.7% and 43.0%, respectively. Infection was the major cause of death (81.6%). ROC curve analysis demonstrated that SOFA (0.92) and SAPS II (0.89) scores calculated within 24h of admission predicted ICU mortality better than the Child-Pugh score (0.79) or MELD scores with (0.79-0.82) or without the incorporation of serum sodium levels (0.82). Statistical analysis showed that the prognostic severity scores, organ replacement therapy, and infection were accurate predictors of mortality. On multivariate analysis, mechanical ventilation, vasopressor therapy, bilirubin level at admission, and infection were independently associated with ICU mortality.
CONCLUSIONS: For cirrhotic patients admitted to the ICU, SAPS II, and SOFA scores predicted ICU mortality better than liver-specific scores. Mechanical ventilation or vasopressor therapy, bilirubin levels at admission and infection in patients with advanced cirrhosis were associated with a poor outcome.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835136     DOI: 10.1016/j.jhep.2011.06.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  43 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  Incidence and Outcomes for Patients With Cirrhosis Admitted to the United Kingdom Critical Care Units.

Authors:  Mark J W McPhail; Francesca Parrott; Julia A Wendon; David A Harrison; Kathy A Rowan; William Bernal
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

3.  The confusion assessment method for the intensive care unit in patients with cirrhosis.

Authors:  Eric S Orman; Anthony Perkins; Marwan Ghabril; Babar A Khan; Naga Chalasani; Malaz A Boustani
Journal:  Metab Brain Dis       Date:  2015-05-07       Impact factor: 3.584

4.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

5.  Organ dysfunctions in patients with alcoholic cirrhosis.

Authors:  Richard Moreau
Journal:  Hepatol Int       Date:  2014-04-03       Impact factor: 6.047

6.  Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Jody C Olson; Ram M Subramanian; Geri Brown; Nicole A Noble; Leroy R Thacker; Patrick S Kamath
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

Review 7.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 8.  Acute-on-Chronic Liver Failure: Recent Concepts.

Authors:  Richard Moreau; Rajiv Jalan; Vicente Arroyo
Journal:  J Clin Exp Hepatol       Date:  2014-10-03

9.  Factors that predict short-term intensive care unit mortality in patients with cirrhosis.

Authors:  Ranjeeta Bahirwani; Marwan Ghabril; Kimberly A Forde; Hemant Chatrath; Karen M Wolf; Lindsay Uribe; K Rajender Reddy; Barry Fuchs; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 11.382

Review 10.  Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice.

Authors:  Katrine Prier Lindvig; Ane Søgaard Teisner; Jens Kjeldsen; Thomas Strøm; Palle Toft; Valentin Furhmann; Aleksander Krag
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.